Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: The AVACROSS study

  1. Nogué, M.
  2. Salud, A.
  3. Vicente, P.
  4. Arriví, A.
  5. Roca, J.M.
  6. Losa, F.
  7. Ponce, J.
  8. Safont, M.J.
  9. Guasch, I.
  10. Moreno, I.
  11. Ruiz, A.
  12. Pericay, C.
Zeitschrift:
Oncologist

ISSN: 1083-7159,  1549-490X

Datum der Publikation: 2011

Ausgabe: 16

Nummer: 5

Seiten: 614-620

Art: Artikel

DOI: 10.1634/THEONCOLOGIST.2010-0285 GOOGLE SCHOLAR lock_openOpen Access editor

Objetivos de desarrollo sostenible

Datenquelle: Scopus